BioNTech Will Price Vaccine Below Market Rates

BioNTech is planning to price the two-shot regimen of the COVID-19 vaccine below “typical market rates” and would even differentiate pricing between regions or nations. The company is currently first in the race to disclose interim information from a large-scale trial showing a highly effective COVID-19 vaccine.

Read more

Toshiba Aims to Create $3 Billion Revenue in Quantum Cryptography

Toshiba announced on Monday morning that it is aiming to create $3 billion in revenue from its advanced cryptographic technology for data protection by the year 2030, as the Japanese giant scrambles to find future growth drivers.

Read more